Video

Dr. Hsi discusses study on 24-hour urine testing in VA population

Author(s):

Urology Times staff

“The rates of testing declined slightly, about 2 absolute percentage points, over the study interval, despite the introduction of guidelines recommending it during the study period,” says Ryan Hsi, MD, FACS.

In this interview, Ryan Hsi, MD, FACS, discusses key findings from his recent study, “Specialist care, metabolic testing, and testing completeness among U.S. veterans with urinary stone disease”. Hsi is an associate professor of urology at Vanderbilt University Medical Center in Nashville, Tennessee.

Related Videos
Oliver Sartor, MD, is featured in this series.
Oliver Sartor, MD, is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Oliver Sartor, MD, is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Oliver Sartor, MD, is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Increasing thiazide doses linked to fewer kidney stone events
August 27th 2024

Increasing thiazide doses linked to fewer kidney stone events

Hannah Clarke
“What this means for patients is that thiazides remain an important option in the toolkit for preventing kidney stone recurrence,” says Ryan S. Hsi, MD, FACS.
What does the BCG shortage look like in 2021?
November 1st 2021

What does the BCG shortage look like in 2021?

Urology Times staff
“I wouldn't be surprised if we have spotty distribution areas of concern for the next several years,” says Sam S. Chang MD, MBA, on the latest episode of the UT podcast Speaking of Urology.
Human kidney stones | Image Credit: © freshidea - stock.adobe.com
July 22nd 2024

Bundled payment program covers kidney stone care

Urology Times staff
"One day, we're going to have to move away from fee for service, so we'd be wise to try to navigate those waters ahead of time, so we're not left dealing with the aftermath when someone else has implemented it for us," says Ruchika Talwar, MD.
Expert discusses gender disparities in bladder cancer care
May 27th 2024

Expert discusses gender disparities in bladder cancer care

Urology Times staff
"In [bladder cancer], many women's diagnosis is delayed because their hematuria or microscopic hematuria is blamed on urinary tract infections rather than cancer," says Amy Luckenbaugh, MD.
Portrait of stressed doctor woman in office | Image Credit: © Alliance - stock.adobe.com
April 29th 2024

The emotional toll of surgical complications on urologic surgeons

Amy N. Luckenbaugh, MD
"It is important as a field that we recognize the potential emotional impact of surgical adverse events," writes Amy N. Luckenbaugh, MD.
Conceptual image for prostate cancer treatment | Image Credit: © Dr_Microbe - stock.adobe.com
April 26th 2024

Dr. Tosoian on screening approaches and tools for prostate cancer

Urology Times staff
"I think in terms of the 2 large tool sets we have, biomarker testing through urine or blood tests and imaging. I think both are only going to get better," says Jeffrey Tosoian, MD, MPH.
© 2024 MJH Life Sciences

All rights reserved.